Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs

Martynas Ridziauskas, Birutė Zablockienė, Ligita Jančorienė, Artūras Samuilis, Rolandas Zablockis, Aušrinė Jackevičiūtė

Open source

DOI
10.3390/medicina57030210
Published
2021-02-26
Container
Medicina
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/medicina57030210,
  title = {Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs},
  author = {Martynas Ridziauskas and Birutė Zablockienė and Ligita Jančorienė and Artūras Samuilis and Rolandas Zablockis and Aušrinė Jackevičiūtė},
  year = {2021},
  journal = {Medicina},
  doi = {10.3390/medicina57030210},
  url = {https://doi.org/10.3390/medicina57030210}
}

RIS

TY  - JOUR
TI  - Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs
AU  - Martynas Ridziauskas
AU  - Birutė Zablockienė
AU  - Ligita Jančorienė
AU  - Artūras Samuilis
AU  - Rolandas Zablockis
AU  - Aušrinė Jackevičiūtė
PY  - 2021
JO  - Medicina
DO  - 10.3390/medicina57030210
UR  - https://doi.org/10.3390/medicina57030210
ER  - 

APA

Ridziauskas, M., Zablockienė, B., Jančorienė, L., Samuilis, A., Zablockis, R., & Jackevičiūtė, A. (2021). Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs. Medicina. https://doi.org/10.3390/medicina57030210

Source records